Clinical trial
2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients
NCT06432166
Study timeline
Study start (estimated)2026-09-01Date precision: day
Registry last updated2026-09-24
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer Diseaseunresolved
Mild Cognitive Impairmentunresolved
Interventions
PlaceboOTHER
Sponsors & collaborators
MTI Biotech Inclead sponsor
Vanderbilt University Medical Centercollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06432166 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.